Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
Launched by NYU LANGONE HEALTH · Jan 16, 2024
Trial Information
Current as of July 30, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is exploring a new exercise program called MoveMend Health, designed to help patients recovering from kidney or liver transplants while they are in the hospital. The goal is to see how well this program works alongside regular occupational therapy, which is a type of treatment that helps people regain their ability to perform daily activities. Researchers want to find out if patients can easily use the program, how many patients sign up for it, and what feedback they give about their experience.
To be eligible for this study, participants should be English-speaking adults aged 65 to 74 who have recently undergone a kidney or liver transplant and have been ordered by their doctor to receive occupational therapy. They should also be alert and not show signs of confusion. However, individuals with severe shoulder injuries or certain other medical conditions that limit their movement may not be able to participate. Those who join can expect to use the MoveMend program in addition to their regular therapy sessions, and their experiences will help researchers understand how beneficial this new approach could be for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English speaking (software program is currently only available in English)
- • Status post kidney or liver transplant this admission
- • Physician orders for occupational therapy evaluation and treatment
- • Orientation Log \> 25
- • Negative for delirium per the Confusion Assessment Method
- Exclusion Criteria:
- • Orthopedic or surgical precautions that limits shoulder range of motion beyond 90 degrees
- • Upper extremity hemiplegia with inability to lift upper extremity against gravity
- • Accommodation code of Intensive Care Unit
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
John Corcoran
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported